Manzo Pharmaceuticals, Inc. (MNZO) Research

Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.

Market snapshot

Symbol
MNZO
Price
$0.00
Day change
0.00%
Market cap
$116.0K
P/E ratio
-9.83x
52-week range
0.00001-0.0001
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Alpha Wastewater, Inc. (AWWI)
  • Black Box Entertainment Ltd. (BBOE)
  • Better For You Wellness, Inc. (BFYW)
  • Chineseworldnet.Com Inc. (CWNOF)
  • IGS Capital Group Limited (IGSC)
  • iTokk, Inc. (IKTO)
  • Jade Art Group Inc. (JADA)
  • Lotus Pharmaceuticals, Inc. (LTUS)

Open Manzo Pharmaceuticals, Inc. (MNZO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.